(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

GIFFORD

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

GIFFORD

ST13

US500000097376078

Class

42

Filing

97376078

Registration

7160858

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

20

Latest update

09/12/2023

Trademark type

Word

Nice classes

42

Filing date

04/22/2022

Registration date

09/12/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/12/2023

Last transaction

09/12/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Foreign priority

First use anywhere

2017-08-00

First use in commerce

2018-04-00

Drawing code

4

Owner type

99

Owner location

Worcestershire, GB

Examiner

FRENCH, CURTIS

Law office

M60

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Gifford Bioscience Limited

Representatives

Katherine P. Califa FOLEY & LARDNER LLP

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Scientific and technological servicesresearch and design in the field of biologybiomedicinebiotechnologymolecular diagnosticsmolecular medicinecell biology; Scientific and technological research consulting services in the field of biologybiomedicinebiotechnologymolecular diagnosticsmolecular medicinecell biology; Industrial research in the field of biologybiomedicinebiotechnologymolecular diagnosticsmolecular medicinecell biology; scientific research services for medical and biomedical purposes; medical and bioscience research services; biomedical research services; medical and bioscience research services in relation to assaysradioligand binding assaysreceptor affinity and occupancy studies and autoradiography; surveying services; exploration services in the field of pharmaceuticals and life sciences; surveying and exploration services in relation to assaysradioligand binding assaysreceptor affinity and occupancy studies and autoradiography; Custom design and development of chemical reagents and biochemical assays; advisoryconsultancy and information services relating to all the aforesaid

Publications

History of USPTO decisions and trademark events.

20 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

09/12/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

09/12/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/27/2023

PUBO

PUBLISHED FOR OPPOSITION

06/27/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/07/2023

FIXD

ELECTRONIC RECORD REVIEW COMPLETE

05/24/2023

ERRR

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

05/19/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/16/2023

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

05/16/2023

GNEA

EXAMINERS AMENDMENT E-MAILED

05/16/2023

CNEA

EXAMINERS AMENDMENT -WRITTEN

05/16/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/01/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/01/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/01/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

02/14/2023

GNRT

NON-FINAL ACTION E-MAILED

02/14/2023

CNRT

NON-FINAL ACTION WRITTEN

02/14/2023

DOCK

ASSIGNED TO EXAMINER

02/09/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/27/2022

NWAP

NEW APPLICATION ENTERED

04/26/2022

Continuous trademark protection

Get notified about every new filing that threatens GIFFORD or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.